Biozentrum, University of Basel, Basel, Switzerland.
Swiss Institute of Bioinformatics, Basel, Switzerland.
Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y. Epub 2021 Jun 7.
Following its emergence in late 2019, the spread of SARS-CoV-2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant's success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes.
自 2019 年末出现以来,通过对病毒基因组序列的系统发育分析,对 SARS-CoV-2 的传播进行了前所未有的详细追踪。尽管该病毒在 2020 年初在全球范围内传播,随后各国关闭了边境,但此后洲际旅行大大减少。然而,2020 年夏天欧洲内部的旅行已经恢复。在这里,我们报告了一种在西班牙初夏发现的 SARS-CoV-2 变体 20E(EU1),并随后在欧洲传播。我们没有发现该变体增加了传染性的证据,而是证明了西班牙发病率上升、旅行恢复以及缺乏有效的筛查和遏制措施如何解释该变体的成功。尽管有旅行限制,但我们估计,到夏季旅行时,20E(EU1) 已被数百次引入欧洲国家,这可能破坏了当地努力将 SARS-CoV-2 感染最小化的努力。我们的研究结果表明,即使在有利的流行病学环境中不存在实质性的传播优势,变体也可以迅速成为主要优势。基因组监测对于了解旅行如何影响 SARS-CoV-2 的传播至关重要,因此为恢复旅行时制定未来的遏制策略提供了信息。